Viewing Study NCT04430192

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:35 PM
Ignite Modification Date: 2025-12-26 @ 11:26 PM
Study NCT ID: NCT04430192
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-11-08
First Post: 2020-05-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy
Sponsor: Peter MacCallum Cancer Centre, Australia
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostatic Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None 177Lu-PSMA View
None Prostate Cancer View
None Radionuclide Therapy View
None Theranostics View
None prostate specific membrane antigen View